Join
Live feed
·
NEWSReleasevia Quantisnow
MIRA Pharmaceuticals Inc. logo

MIRA Pharmaceuticals Secures Worldwide Rights for Ketamir-2, Expanding Global IP Portfolio Across 10 Major Markets Ahead of Phase 2a in CIPN

ByQuantisnow·Wall Street's wire, on your screen.
MIRA· MIRA Pharmaceuticals Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MIRA (MIRA Pharmaceuticals Inc.) and more on Quantisnow.